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Background and Purpose. White matter changes (WMCs), or leukoaraiosis (LA), are associated with increased age, hypertension,
diabetes mellitus, and history of stroke. Although several lines of evidence suggest a role of atherosclerosis in atherothrombotic
vascularevents,theirinvolvementinLAremainstobedetermined.Ourstudyexaminesthisassociationinischemicstrokepatients.
Methods. One hundred and seventy consecutive ischemic stroke or transient ischemic attack (TIA) patients were included. All
patients underwent brain computed tomography (CT) with assessment of the extension and severity of WMCs, carotid arteries
duplex scan with measurements of intima-media thickness (IMT) and plaques. Results. Seventy-two patients (42.4%) were found
to have white matter lesions, of whom 28.8% had advanced LA. Mean IMT was signiﬁcantly higher in patients with LA and with
advanced LA (P = 0.002, P = 0.003, resp.). In addition, LA and LA severity were associated with existence of carotid plaque
(P = 0.007, P = 0.004, resp.). In multivariate logistic regression analysis, including all vascular risk factors, LA was found to be
associated with age and IMT. Conclusion. This study reinforces the tight association between LA and carotid atherosclerosis in
ischemic stroke patients. We conclude that a chronic atherosclerotic disease underlies the pathophysiology of leukoaraiosis and its
progression.
1.Objectives
Cerebral white matter changes, also known as leukoaraiosis
[1] (LA), are frequently observed on computed tomography
(CT) and magnetic resonance imaging (MRI) brain scans
of elderly individuals [2–4]. These changes are seen on CT
as bilateral patchy or diﬀuse areas of hypodensity with ill-
deﬁned margins or hyperintensities on T2-weighted MRI
scans involving the periventricular and centrum semiovale
white matter [5]. Although the pathogenesis of LA is not
completely elucidated, previous studies have shown that
white matter lesions are more common with increasing age,
hypertension, diabetes mellitus, and where there is a history
of stroke [6]. Moreover, in a large cohort of consecutive
patients hospitalized for stroke or transient ischemic attack
(TIA),LApredictedpoorfunctionalrecoveryduringtheﬁrst
year following stroke onset [7].
Possible contributory factors include occlusive extra-
cranial arterial disease, small vessel arteriosclerosis, tran-
sient decreases in local perfusion because of autoregulatory
dysfunction, and microembolic disease [6]. While carotid
atherosclerosis has been demonstrated to have strong rela-
tionship with stroke and small-vessel disease, its association
with LA is controversial [8, 9]. Inﬂammatory processes are
associated with the pathogenesis of atherosclerosis and cere-
bral small-vessel disease [10, 11] and also play a role in the
response to ischemic events that result from atherosclerosis
[11].
In the current study, we examined the association of
carotid atherosclerosis, deﬁned by intima-media thickness
(IMT) and prevalence of plaques, with LA in ischemic stroke
patients.
2. Patients andMethods
2.1. Patients. One hundred and seventy patients admitted
consecutively to the Department of Emergency at the Tel-
Aviv Sourasky Medical Center, Tel Aviv, Israel, with a2 The Scientiﬁc World Journal
documented event of acute ischemic stroke or transient
ischemic attack (TIA) between January 2003 and April 2005
were included in the study. Stroke was diagnosed by an
experienced vascular neurologist and supported by a CT
scan. Exclusion criteria were stroke resulting from trauma
or an invasive procedure, cerebral hemorrhage, history of
malignant tumor, autoimmune disease, and coagulation
disorders.
A written informed consent was obtained from all
patients who were enrolled and signed by the patients or a
ﬁrst-degree relative in case of aphasia, as approved by the
local Institutional Ethics Committee.
The stroke subtypes were classiﬁed according to the
TOAST classiﬁcation: large-artery atherosclerosis, cardioem-
bolism, small-vessel occlusion, stroke of other determined
etiology, and stroke of undetermined etiology [12]. Neuro-
logicalimpairment wasassessedusing theNational Institutes
of Health Stroke Scale (NIHSS) [13].
2.2. Diagnosis of Leukoaraiosis. B r a i nc o m p u t e dt o m o gr a p h y
(CT) scans were performed on all the patients within 24
hours of admission. Scanning was carried out without
contrast enhancement and with 10mm continuous slices. A
single trained neurologist who was blinded to the patients’
clinical status evaluated the existence, location, and size of
brain infarcts on CT images. White matter lesions were
deﬁned as periventricular or subcortical, areas of decreased
attenuation below that expected for normal white matter.
The changes were always diﬀusely distributed within the
white matter.
Leukoaraiosis was deﬁned as ill-deﬁned and moderately
hypodense areas of >5mm in any CT scan dimension [14].
Extension and severity of CT white matter changes (WMCs)
were rated according to the score of Blennow et al. [15]. For
the purpose of this study, we classiﬁed scans as advanced LA
for Blennow score above 1 (therefore, score 0 represents no
lesion, 1 is mild LA in one region-frontal, parietal, occipital;
scores 2 and 3 are advanced LA in two or more regions).
2.3. Evaluation of Carotid Atherosclerosis. Duplex carotid
ultrasonography was performed to evaluate the severity of
carotid atherosclerosis. All ultrasound examinations were
performed with a 128XP/10 Acuson equipped with a 7.5-
MHz linear-array transducer, focus depth of 40mm, and
frame rate of 15Hz. The intima-media thickness (IMT) was
deﬁnedas the distance between the intimal-luminal interface
and the medial-adventitial interface. We calculated the mean
carotidarteryIMT(meanIMT)byaveragingthethicknessat
4sitesatthefarwallsofboththerightandleftdistalcommon
carotid artery [16, 17]. The subjects were also classiﬁed
according to the presence of well-deﬁned atherosclerotic
plaques. Plaques were deﬁned as a focal structure that
encroached more than 0.5mm into the arterial lumen,
or 50% of the surrounding intima-media thickness (IMT)
value, or demonstrated a thickness of >1.5mm as measured
from the media-adventitia interface to the intima-lumen
interface [17]. The ultrasound examination and assessments
were performed by expert technician blinded to clinical and
CT features.
2.4. Deﬁnitions of Risk Factors. Diabetes mellitus was deﬁned
as a fasting blood glucose of >126mg/dL or the use of insulin
or oral hypoglycemic agents; hypertension as intermittent
blood pressure measurements of >140/90mmHg or the use
of antihypertensive medications. For individuals without
a fasting lipid proﬁle, hyperlipidemia was recorded if the
diagnosis of hyperlipidemia was included in their medical
records or if they were receiving lipid-lowering medication
(HMG-CoA reductase inhibitors or ﬁbrates). For individuals
with valid lipid proﬁles, it was deﬁned by the low-density
lipoprotein (LDL) or non-high-density lipoprotein (non-
HDL) cholesterol concentrations (in individuals displaying
elevated triglyceride concentrations of ≥2.26mmol/L) above
the recommended levels according to the risk proﬁle deﬁned
by the updated ATP III recommendations [18] or the intake
of lipid-lowering medication; current smokers as those
smoking at least 5 cigarettes per day.
2.5. Statistical Analysis. A l lc o n t i n u o u sd a t aw e r es u m m a -
rized and displayed as mean ± SD. Since IMT values have a
non-normal distribution, a logarithmic transformation was
employed, and all results expressing IMT values were back-
transformed to geometric means ± SD. Demographic and
clinical data between stroke patients with and without LA
were compared by the χ2 test and Student’s t-test. Multi-
variate logistic regression analyses were used to assess the
relationshipofLAorLAseveritywiththefollowingvariables:
IMT (bellow and above median = 0.65mm), age, gender,
smoking, diabetes mellitus, hypertension, hyperlipidemia,
and medications. P<0.05 was considered statistically
signiﬁcant. SPSS/WIN (version 15.0, SPSS INC, Chicago, IL,
USA) software was used to carry out all statistical analyses.
3. Results
3.1. Patient Characteristics. Of the 170 acute stroke patients
enrolled (mean ± SD age 66.4 ± 13.4 years, 104 men
a n d6 6w o m e n ) ,9 4h a dl a c u n a rs t r o k e ,3 2h a dl a r g e -
artery atherosclerotic stroke, 12 had cardioembolic stroke, 1
had stroke of undetermined etiology, and 31 had transient
ischemic attack (TIA). In addition to stroke, 28.2% of the
patients had diabetes mellitus, 46.7% had hyperlipidemia,
62.7% had hypertension, and 26.2% are current smokers.
Seventy-two patients (42.4%) were found to have 1 or more
white-matter lesions or leukoaraiosis (LA) on CT images
located in frontal, parietal, or occipital region. Of the acute
stroke patients, 49 patients (28.8%) were recorded to have
advanced LA. Figure 1 illustrates examples of an image from
a patient suﬀering from LA in one region (Figure 1(a))a n d
a patient suﬀering from advanced LA (Figure 1(b)). The
characteristics of stroke patients with and without LA are
summarized in Table 1. Stroke patients with LA diﬀered
signiﬁcantly from stroke patients without LA in their age
(71.4 ± 11.3v e r s u s6 2 .6 ± 13.7y e a r s ,P<0.001) and the
prevalence of hypertension (74.6% versus 54.1%, P = 0.006)The Scientiﬁc World Journal 3
Table 1: Risk factors and clinical characteristics of stroke patients with and without leukoaraiosis.
No
Leukoaraiosis Leukoaraiosis
Index (n = 98) (n = 72) P-value
Age, years 62.6 ± 13.7 71.4 ± 11.3 <0.001
Male gender, % 62.0 59.7 0.770
BMI, kg/m2 27 ± 4.5 26.8 ± 4.5 0.700
Diabetes mellitus, % 22.4 36.1 0.051
Hypertension, % 54.1 74.6 0.006
Hyperlipidemia, % 45.9 47.9 0.800
Current smoker, % 29.8 21.4 0.230
Ever smoker, % 56.8 53.5 0.670
Mean IMT∗,m m 0 . 8 1± 1.12 0.86 ± 1.13 0.002
Median IMT, (IQR), mm 0.60 (0.55–0.74) 0.70 (0.6–0.84) 0.002
Carotid plaque/s, % 63.3 82.6 0.007
NIHSS 3.9 ± 4.4 4.3 ± 3.4 0.580
Medication use
Acetylsalicylic acid, % 33.7 50.0 0.032
Clopidogrel, % 1.0 6.9 0.039
Beta Blockers, % 21.4 33.3 0.082
Calcium blockers, % 14.3 29.2 0.018
ACE Inhibitors, % 30.6 45.8 0.042
ARBs, % 1.0 4.2 0.181
HMG-CoA
reductaseinhibitors, % 21.6 25.0 0.609
Within lacunar strokes, % 50.0 50.0 0.121
BMI indicates body mass index; IMT: intima-media thickness; NIHSS: National Institutes of Health Stroke Scale; ACE: angiotensin converting enzyme;A R B :
angiotensin receptor blockers; HMG-CoA, 3-hydroxy-3-methylglutaryl-Coenzyme A.
∗Data were logarithmically transformed before analysis, presented is the geometric mean (SD).
(a) Leukoaraiosis in 1 region (frontal) marked by
arrow
(b) Advanced Leukoaraiosis (in bilateral frontal and
occipital regions) marked by arrows
Figure 1: Two examples illustrating degrees of LA in CT scan.4 The Scientiﬁc World Journal
Table 2: (a) OR (95% CI) for incidence of leukoaraiosis. (b) OR (95% CI) for severity of white-matter lesions.
Multivariate logistic regression analysis
(a) OR (95% CI) (b) OR (95% CI)
Adjusted for gender, BMI, ever smoking,
hypertension, diabetes mellitus,
hyperlipidemia, medication use,
acetylsalicylic acid, clopidogrel, beta
blockers, calcium blockers, ACE
inhibitors, ARBs, HMG-CoA reductase
inhibitors, stroke history, stroke etiology
for Leukoaraiosis
occurrence
for severity of white
matter lesions
Age, years 1.043 (1.012–1.075),
P = 0.006
1.065 (1.027–1.103),
P = 0.001
IMT above median (0.65mm) 2.503 (1.181–5.302),
P = 0.017
3.012 (1.315–6.897),
P = 0.009
OR indicates odds ratio; CI: conﬁdence interval; BMI: body mass index; ACE: angiotensin converting enzyme; ARB: angiotensin receptor blockers; HMG-
CoA, 3-hydroxy-3-methylglutaryl-Coenzyme A; IMT: intima-media thickness.
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Figure 2: Prevalence (%) of leukoaraiosis by median of intima-media thickness (IMT). ∗P computed by χ2 analysis.
and diabetes mellitus (36.1% versus 22.4%, P = 0.051)
(Table 1).
3.1.1. Relationship between LA and Carotid Atherosclerosis.
We observed signiﬁcantly increased mean IMT measures in
stroke patients with LA compared to those without it (P =
0.002). Also, LA was associated with carotid plaque existence
(χ2 = 7.151, P = 0.013), (Table 1).
We employed a logistic regression model in a stepwise
forward manner. This encompassed age, gender, body mass
index, use of acetylsalicylic acid, clopidogrel, beta blockers,
calcium blockers, ACE inhibitors, ARBs, HMG-CoA reduc-
tase inhibitors, vascular risk factors, stroke history, stroke
etiology, and mean IMT. The only two variables retained
in the model for LA occurrence were IMT above 0.65mm
and age (O.R. 1.043, 95% CI 1.012–1.075, P = 0.006; O.R.
2.503, 95% CI 1.181–5.302, P = 0.017, resp.), (Table 2(a),
(Figure 2).
3.1.2. Relationship between Severity of WMCs and Carotid
Atherosclerosis. Stroke patients with advanced WMCs repre-
sented 28.8% of the sample. Stroke patients with advanced
WMCs diﬀered signiﬁcantly from stroke patients without
advanced WMCs in their age (P<0.001), and the prevalence
of hypertension (P = 0.015), but not in other cardiovascular
risk factors (Table 3). Measures of carotid IMT were higher
in patients with advanced WMCs (P = 0.003) and WMCs
severity was associated with carotid plaque existence (χ2 =
8.5, P = 0.004), (Table 3).
In logistic regression analysis, including age, gender,
body mass index, use of acetylsalicylic acid, clopidogrel, beta
blockers, calcium blockers, ACE inhibitors, ARBs, HMG-
CoA reductase inhibitors, and all vascular risk factors,
severity of WMCs was found to be associated with age and
IMT above 0.65mm (O.R. 1.065, 95% CI 1.027–1.103, P<
0.001; O.R. 3.012, 95% CI 1.315–6.897, P = 0.009; resp.).
4. Discussion
This study demonstrates a signiﬁcant relation between
carotid atherosclerosis, reﬂected as IMT and existence of
carotid plaques, and LA in a cohort of acute ischemic
stroke and TIA patients. Previous studies have shown
that white matter lesions are related to age, hypertension,The Scientiﬁc World Journal 5
Table 3:Riskfactorsandcarotidultrasonographycharacteristicsby
severity of WMCs.
Advanced WMCs
No Yes P-value
(n = 121) (n = 49)
Age, years 63.6 ± 13.4 73.1 ± 10.8 <0.001
Male gender 62.0 59.2 0.734
BMI, kg/m2 27.1 ± 4.6 26.4 ± 4.1 0.373
Diabetes mellitus, % 26.4 32.7 0.415
Hypertension, % 57.0 77.1 0.015
Hyperlipidemia, % 46.3 47.9 0.848
Current smoker, % 29.1 19.1 0.192
Ever smoker, % 56.8 52.1 0.581
Mean IMT∗,m m 0 . 8 1± 1.12 0.87 ± 1.13 0.003
Carotid plaque/s, % 64.9 87.5 0.004
Within Lacunar
strokes, % 68.5 31.5 0.834
WMC indicates white matter changes; IMT: intima-media thickness.
∗Data were logarithmically transformed before analysis, presented is the
geometric mean (SD).
diabetes, and stroke history [6]. We report that age and
IMT are more signiﬁcant contributors to LA compared to
other cardiovascular risk factors, as seen in multivariate
regression analysis, although the prevalence of hypertension
and diabetes mellitus was higher in patients with LA.
Additionally, stroke patients with carotid plaques tended to
have more prevalence of WMCs as well as advanced WMCs
than patients free of carotid plaques. Breteler et al. [19]
reported that WMCs were related to atherosclerosis, deﬁned
by increased common carotid IMT and carotid plaques.
Similarly, Manolio et al. [8] found that infarcts deﬁned by
MRI and white matter score were strongly associated with
carotid IMT and stenosis degree after adjustment for age and
sex. Furthermore, Pico et al. [20] conﬁrmed the relationship
between carotid IMT and plaques with WMCs in a 4-year
follow-up study of healthy subjects.
Our study provided further evidence that the relation
between carotid atherosclerosis and WMCs is independent
of other vascular risk factors and history of stroke. Moreover,
strengthening for those ﬁndings received by the multivariate
analysis, where the ﬁndings that the only signiﬁcant and
independent predictors of advanced LA were age and
elevated IMT as a marker of carotid atheroclerosis. It has
beensuggestedthatWMCspr ogressgraduallyov ertimewith
the accumulation of vascular risk factors [21]. Therefore
our ﬁndings are in agreement with the notion that IMT
and carotid plaques are a cumulative marker of cardiovas-
cular risk. It can be assumed that patients suﬀering from
advanced atherosclerosis (reﬂected as plaque formation) are
in increased risk to develop advanced WMCs, based on our
analysis of patients with advanced WMCs.
The present study has a limitation of possible misclas-
siﬁcation in the diagnosis of leukoaraiosis as the diagnosis
was based on CT scans rather than MR. However, the use
of CT scan for the assessment of leukoaraiosis was found to
be a reliable diagnostic method. Previous studies have shown
a good intrareader agreement in the use of CT scan for the
assessment of leukoaraiosis [22, 23]. In fact, although CT is
widelyrecognizedtobelesssensitivetowhite-matterchanges
than MRI, it is still the most easily accessible neuroimaging
procedure in many centers and often the only available
method for brain imaging.
In summary, this study reinforces the relationship
between LA and carotid atherosclerosis in a population of
ischemicstrokepatients,althoughitisnotpossibletosuggest
the probable causative relation between them. This associ-
ation emerged over most vascular risk factors, as seen in
multivariate regression analysis. Also, severity of WMCs was
strongly related to carotid IMT and plaques. Together, these
observations support diagnostic measurements of carotid
IMT in stroke patients as an additional clinical tool for
risk stratiﬁcation. We suggest that a chronic atherosclerotic
diseaseisprobablythebasicpathophysiologyofleukoaraiosis
and its progression.
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